REDHILL BIOPHARMA LTD's ticker is RDHL and the CUSIP is 757468103. A total of 56 filers reported holding REDHILL BIOPHARMA LTD in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $702 | -82.4% | 5,000 | -28.6% | 0.00% | – |
| Q3 2022 | $4,000 | -42.9% | 7,000 | -6.7% | 0.00% | – |
| Q2 2022 | $7,000 | -63.2% | 7,500 | 0.0% | 0.00% | – |
| Q1 2022 | $19,000 | 0.0% | 7,500 | 0.0% | 0.00% | – |
| Q4 2021 | $19,000 | -44.1% | 7,500 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $34,000 | -34.6% | 7,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $52,000 | -100.0% | 7,500 | -50.0% | 0.00% | 0.0% |
| Q1 2021 | $109,800,000 | +274400.0% | 15,000 | +200.0% | 0.00% | 0.0% |
| Q4 2020 | $40,000 | +1233.3% | 5,000 | +900.0% | 0.00% | – |
| Q2 2020 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 500 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ibex Investors LLC | 1,892,593 | $15,292,000 | 6.10% |
| GAGNON SECURITIES LLC | 281,080 | $2,271,000 | 0.36% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 2,029,195 | $16,396,000 | 0.32% |
| Annandale Capital, LLC | 43,532 | $352,000 | 0.29% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 23,000 | $186,000 | 0.12% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 20,328 | $164,000 | 0.10% |
| Claret Asset Management Corp | 54,972 | $444,000 | 0.09% |
| Migdal Insurance & Financial Holdings Ltd. | 890,339 | $7,194,000 | 0.08% |
| Shay Capital LLC | 47,800 | $386,000 | 0.08% |
| ARS Investment Partners, LLC | 77,714 | $628,000 | 0.08% |